A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis

Macrophage Polarization

Murray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981

GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects

Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial

Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237

Liver Macrophages in Tissue Homeostasis and Disease

Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424

A lipidomic analysis of nonalcoholic fatty liver disease

Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338

Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages

Huang, S. C., Everts, B., Ivanova, Y., O’Sullivan, D., Nascimento, M., Smith, A. M., Beatty, W. L., Love-Gregory, L. D., Lam, W. Y., O’Neill, C. M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2956 · Cited by 1,256

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035

Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions

Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908

Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation

Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 839

Retinoid-Related Orphan Receptors (RORs): Critical Roles in Development, Immunity, Circadian Rhythm, and Cellular Metabolism

Jetten, A. M. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07003 · Cited by 700

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002

Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions

Dyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., Souza, F. D. C., Dalli, J., Durand, T., Galano, J., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 707

Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits

Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564

Specialized pro-resolving mediator network: an update on production and actions

Chiang, N., & Serhan, C. N. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200018 · Cited by 455

Hepatic fibrosis 2022: Unmet needs and a blueprint for the future

Friedman, S. L., & Pinzani, M. (2022) · Hepatology · doi:10.1002/hep.32285 · Cited by 430

Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions

Chiang, N., Libreros, S., Norris, P. C., de la Rosa, X., & Serhan, C. N. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129448 · Cited by 259

A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation

Vujkovic, M., Ramdas, S., Lorenz, K. M., Guo, X., Darlay, R., Cordell, H. J., He, J., Gindin, Y., Chung, C., Myers, R. P., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01078-z · Cited by 205

Hepatic macrophages: Key players in the development and progression of liver fibrosis

Cheng, D., Chai, J., Wang, H., Fu, L., Peng, S., & Ni, X. (2021) · Liver International · doi:10.1111/liv.14940 · Cited by 188

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158

Innate Immunity in Diabetic Wound Healing: Focus on the Mastermind Hidden in Chronic Inflammatory

Geng, K., Ma, X., Jiang, Z., Huang, W. G., Gao, C., Pu, Y., Luo, L., Xu, Y., & Xu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.653940 · Cited by 125

Maresin 1 promotes nerve regeneration and alleviates neuropathic pain after nerve injury

Wei, J., Su, W., Zhao, Y., Wei, Z., Hua, Y., Xue, P., Zhu, X., Chen, Y., & Chen, G. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02405-1 · Cited by 113

Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation

Sugimoto, S., Mena, H. A., Sansbury, B. E., Kobayashi, S., Tsuji, T., Wang, C., Yin, X., Huang, T. L., Kusuyama, J., Kodani, S. D., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00590-0 · Cited by 119

The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD

Hong, T., Chen, Y., Li, X., & Lü, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6889533 · Cited by 110

Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis

Zhou, J.-E., Sun, L., Liu, L., Jia, Y., Han, Y., Shao, J., Wang, J., Wang, Y., Yu, L., & Yan, Z. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.038 · Cited by 104

Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch

Ji, R. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-084047 · Cited by 109

Immuno‐Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega‐3 Fatty Acids in Metabolic Syndrome

Kwon, Y. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900824 · Cited by 93

ROR: Nuclear Receptor for Melatonin or Not?

Ma, H., Kang, J., Fan, W., He, H., & Huang, F. P. (2021) · Molecules · doi:10.3390/molecules26092693 · Cited by 81

Hepatic Stellate Cell-Immune Interactions in NASH

Carter, J. K., & Friedman, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867940 · Cited by 79

Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation

Rodrí­guez, M. J., Sabaj, M., Tolosa, G., Vielma, F. H., Zúñiga, M. J., González, D. R., & Zúñiga‐Hernández, J. (2021) · Cells · doi:10.3390/cells10123406 · Cited by 83

Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair

Tiberi, M., & Chiurchiù, V. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.673549 · Cited by 80

Maresin-1 and Inflammatory Disease

Saito‐Sasaki, N., Sawada, Y., & Nakamura, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031367 · Cited by 78

Damage-mediated macrophage polarization in sterile inflammation

Koncz, G., Jenei, V., Tóth, M., Váradi, E., Kardos, B., Bácsi, A., & Mázló, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1169560 · Cited by 74

Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances

Musso, G., Saba, F., Cassader, M., & Gambino, R. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101238 · Cited by 71

Triglyceride lowering by omega-3 fatty acids: a mechanism mediated by N-acyl taurines

Bornfeldt, K. E. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147558 · Cited by 58

Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis

Rui, L., & Lin, J. D. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-105200 · Cited by 59

Treating inflammation to combat non-alcoholic fatty liver disease

Wiering, L., & Tacke, F. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0194 · Cited by 59

Beneficial Effects of Omega-3 Fatty Acids on Obesity and Related Metabolic and Chronic Inflammatory Diseases

Jerab, D., Blangero, F., da Costa, P. C. T., Alves, J. L. D. B., Kéfi, R., Jamoussi, H., Morio, B., & Eljaafari, A. (2025) · Nutrients · doi:10.3390/nu17071253 · Cited by 66

Inhibition of nuclear receptor RORα attenuates cartilage damage in osteoarthritis by modulating IL-6/STAT3 pathway

Liang, T., Chen, T., Qiu, J., Gao, W., Qiu, X., Zhu, Y., Wang, X., Chen, Y., Zhou, H., Deng, Z., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04170-0 · Cited by 54

Maresin-1 suppresses IL-1β-induced MMP-13 secretion by activating the PI3K/AKT pathway and inhibiting the NF-κB pathway in synovioblasts of an osteoarthritis rat model with treadmill exercise

Lu, J., Feng, X., Zhang, H., Wei, Y., Yang, Y., Tian, Y., & Bai, L. (2020) · Connective Tissue Research · doi:10.1080/03008207.2020.1780218 · Cited by 52

Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases

Videla, L. A., Valenzuela, R., del Campo, A., & Zúñiga‐Hernández, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115528 · Cited by 53

Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid

Beyer, M. P., Videla, L. A., Farías, C., & Valenzuela, R. (2023) · Nutrients · doi:10.3390/nu15153317 · Cited by 54

Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis

Zhang, X., She, Z., Wang, J., Sun, D., Shen, L., Xiang, H., Cheng, X., Ji, Y., Huang, Y., Li, P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abg8117 · Cited by 49

Resolvin D1 protects against sepsis‐induced cardiac injury in mice

Wang, M., Liu, M., Zhang, J., Liu, J., Ye, J., Xu, Y. Q., Wang, Z., Ye, D., Zhao, M., & Wan, J. (2020) · BioFactors · doi:10.1002/biof.1668 · Cited by 47

Maresin-1 resolution with RORα and LGR6

Im, D. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101034 · Cited by 47

Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders

Duan, J., Song, Y., Zhang, X., & Wang, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.646491 · Cited by 47

Bioactive signalling lipids as drivers of chronic liver diseases

Kaffe, E., Tisi, A., Magkrioti, C., Aidinis, V., Mehal, W. Z., Flavell, R. A., & Maccarrone, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.029 · Cited by 45

Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders

Han, Y., KyeongJin, L., Saha, A., Han, J., Choi, H., Noh, M., Lee, Y., & Lee, M. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2021.094 · Cited by 43

A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH

Fraser, D. A., Wang, X., Lund, J., Nikolić, N., Iruarrizaga-Lejarreta, M., Skjaeret, T., Alonso, C., Kastelein, J. J. P., Rustan, A. C., Kim, Y. O., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.004 · Cited by 41

Maresin: Macrophage Mediator for Resolving Inflammation and Bridging Tissue Regeneration—A System-Based Preclinical Systematic Review

Liu, W., Yang, Y.-H., Wang, Y.-C., Chang, W., & Wang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311012 · Cited by 40

Alzheimer’s Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?

Miyazawa, K., Fukunaga, H., Tatewaki, Y., Takano, Y., Yamamoto, S., Mutoh, T., & Taki, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165783 · Cited by 37

Bioactive Lipid Mediators in the Initiation and Resolution of Inflammation after Spinal Cord Injury

David, S., & López‐Vales, R. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.04.026 · Cited by 41

Role of Specialized Pro-Resolving Mediators in Neuropathic Pain

Leuti, A., Fava, M., Pellegrini, N., & Maccarrone, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.717993 · Cited by 38

The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic allies

Giardini, E., Moore, D., Sadlier, D. M., Godson, C., & Brennan, E. P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118615 · Cited by 41

Specialized pro-resolving lipid mediators: a key player in resolving inflammation in autoimmune diseases

Zhang, Q., Wang, Y., Zhu, J., Zou, M., Zhang, Y., Wu, H., & Jin, T. (2025) · 中国科学通报：英文版 · doi:10.1016/j.scib.2024.07.049 · Cited by 35

Targeting peripheral immune organs with self-assembling prodrug nanoparticles ameliorates allogeneic heart transplant rejection

Zhou, K., Chen, X., Zhang, L., Yang, Z., Zhu, H. H., Guo, D., Su, R., Chen, H., Li, H., Song, P., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16748 · Cited by 35

An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides

Grevengoed, T. J., Trammell, S. A. J., Svenningsen, J. S., Makarov, M. V., Nielsen, T. S., Jacobsen, J. C., Treebak, J. T., Calder, P. C., Migaud, M. E., Cravatt, B. F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143861 · Cited by 34

Maresin 1 protects the liver against ischemia/reperfusion injury via the ALXR/Akt signaling pathway

Tang, D., Fu, G., Li, W., Sun, P., Loughran, P., Deng, M., Scott, M. J., & Billiar, T. R. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00280-9 · Cited by 34

MCTR1 inhibits ferroptosis by promoting NRF2 expression to attenuate hepatic ischemia-reperfusion injury

Ye, J., Peng, J., Liu, K., Zhang, T., & Huang, W. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00354.2021 · Cited by 35

Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development

Alba, M. M., Ebright, B., Hua, B., Slarve, I., Zhou, Y., Jia, Y., Louie, S. G., & Stiles, B. L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1098467 · Cited by 32

Decreased Plasma Maresin 1 Concentration Is Associated with Diabetic Foot Ulcer

Tian, M., Huang, B., He, N., Sun, L., Du, G., Gong, X., Xu, Y., Zheng, Y., Zheng, H., & Qu, H. (2020) · Mediators of Inflammation · doi:10.1155/2020/4539035 · Cited by 31

Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease

Chen, T., Dalton, G. D., Oh, S., Maeso‐Díaz, R., Du, K., Meyers, R. A., Guy, C. D., Abdelmalek, M. F., Henao, R., Guarnieri, P., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.12.008 · Cited by 31

Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice

Laiglesia, L. M., Escoté, X., Sáinź, N., Félix‐Soriano, E., Santamaría, E., Collantes, M., Fernández‐Galilea, M., Colón-Mesa, I., Martínez‐Fernández, L., Quesada‐López, T., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101749 · Cited by 32

Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets

Liu, Y., Hao, Y., Boeckmans, J., Rodrigues, R. M., & He, Y. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108353 · Cited by 30

The diverse roles of macrophages in metabolic inflammation and its resolution

Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 31

Mechanisms of liver fibrosis in metabolic syndrome

Mehal, W. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100015 · Cited by 28

Arachidonic acid metabolism in metabolic dysfunction–associated steatotic liver disease and liver fibrosis

Ma, Y., Jiang, J., Zhao, C., Wei, B., & Gao, J. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000802 · Cited by 31

Nobiletin Alleviates Non-alcoholic Steatohepatitis in MCD-Induced Mice by Regulating Macrophage Polarization

Wang, S.-W., Lan, T., Sheng, H., Zheng, F., Lei, M.-K., Wang, L.-X., Chen, H.-F., Xu, C.-Y., & Zhang, F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.687744 · Cited by 28

Role of Omega-3 Fatty Acids as Non-Photic Zeitgebers and Circadian Clock Synchronizers

Checa-Ros, A., & D’Marco, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012162 · Cited by 28

Maresin 1 Regulates Hepatic FGF21 in Diet‐Induced Obese Mice and in Cultured Hepatocytes

Martínez‐Fernández, L., González‐Muniesa, P., Sáinź, N., Laiglesia, L. M., Escoté, X., Martínez, J. A., & Moreno-Aliaga, M. J. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900358 · Cited by 26

Maresin-1 induces cardiomyocyte hypertrophy through IGF-1 paracrine pathway

Wahyuni, T., Kobayashi, A., Tanaka, S., Miyake, Y., Yamamoto, A., Bahtiar, A., Mori, S., Kametani, Y., Tomimatsu, M., Matsumoto, K., et al. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00568.2020 · Cited by 27

Maresin1 Decreased Microglial Chemotaxis and Ameliorated Inflammation Induced by Amyloid-β 42 in Neuron-Microglia Co-Culture Models

Yin, P., Wang, S., Wei, Y., Wang, X., Zhang, J., Yin, X., Feng, J., & Zhu, M. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190682 · Cited by 24

Effects of Maresin 1 (MaR1) on Colonic Inflammation and Gut Dysbiosis in Diet-Induced Obese Mice

León, I. C., Quesada‐Vázquez, S., Sáinź, N., Guruceaga, E., Escoté, X., & Moreno-Aliaga, M. J. (2020) · Microorganisms · doi:10.3390/microorganisms8081156 · Cited by 24

Maternal diabetes-mediated RORA suppression in mice contributes to autism-like offspring through inhibition of aromatase

Yu, H. Y., Niu, Y., Jia, G., Liang, Y., Chen, B., Sun, R., Wang, M., Huang, S., Zeng, J., Lu, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03005-8 · Cited by 24

Omega-3 derivatives, specialized pro-resolving mediators: Promising therapeutic tools for the treatment of pain in chronic liver disease

Mariqueo, T. A., & Zúñiga‐Hernández, J. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102095 · Cited by 24

Resolution of chronic inflammation and cancer

Tezcan, G., Yakar, N., Hastürk, H., Dyke, T. E. V., & Kantarcı, A. (2024) · Periodontology 2000 · doi:10.1111/prd.12603 · Cited by 25

Maresin-1 and its receptors RORα/LGR6 as potential therapeutic target for respiratory diseases

Zhao, M., Li, C., Zhang, J., Yin, Z., Zheng, Z., Wan, J., & Wang, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106337 · Cited by 23

Therapeutic potential of macrophage colony-stimulating factor in chronic liver disease

Keshvari, S., Genz, B., Teakle, N., Caruso, M., Ferrari-Cestari, M., Patkar, O. L., Tse, B. W., Sokolowski, K. A., Ebersbach, H., Jascur, J., et al. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049387 · Cited by 21

Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death

Hwang, S., Park, S., Kim, J. H., Bang, S.-B., Kim, H., Ka, N., Ko, Y., Kim, S.-S., Lim, G. Y., Lee, S., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121827 · Cited by 22

Omega-3 pleiad: The multipoint anti-inflammatory strategy

Batista, E. D. S., Nakandakari, S. C. B. R., da Silva, A. S. R., Pauli, J. R., de Moura, L. P., Ropelle, E. R., Camargo, E. A., & Cintra, D. E. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2146044 · Cited by 22

Matrix stiffness regulates bone repair by modulating 12-lipoxygenase-mediated early inflammation

Yao, D., Qiao, F., Song, C., & Lv, Y. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112359 · Cited by 21

Lipid metabolism in tumor immunology and immunotherapy

Duong, L. K., Corbali, H. I., Riad, T. S., Ganjoo, S., Nanez, S., Voss, T. A., Barsoumian, H. B., Welsh, J. W., & Cortez, M. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1187279 · Cited by 21

Protective Potential of Maresins in Cardiovascular Diseases

Liu, M., He, H., & Chen, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.923413 · Cited by 21

Proresolving lipid mediators and liver disease

Clària, J., Flores‐Costa, R., Duran‐Güell, M., & López‐Vicario, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159023 · Cited by 19

Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders

Kim, N., & Shin, H. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179598 · Cited by 19

The Role of Retinoic-Acid-Related Orphan Receptor (RORs) in Cellular Homeostasis

Nematisouldaragh, D., Kirshenbaum, E., Uzonna, M., Kirshenbaum, L. A., & Rabinovich-Nikitin, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111340 · Cited by 21

Low serum Maresin-1 levels are associated with non-alcoholic fatty liver disease: a cross-sectional study

Xia, F., Wang, H., Ye, T., Fu, X.-L., Tan, X., Zeng, Y., Fan, J., & Xu, Y. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01518-5 · Cited by 18

Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators

Yasmeen, N., Selvaraj, H., Lakhawat, S. S., Datta, M., Sharma, P. K., Jain, A., Khanna, R., Srinivasan, J., & Kumar, V. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115437 · Cited by 17

Effects of high-fat diet on liver injury after small bowel resection

Onufer, E. J., Han, Y., Czepielewski, R. S., Courtney, C. M., Sutton, S., Randolph, G. J., & Warner, B. W. (2020) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2020.02.037 · Cited by 18

A cell-free difunctional demineralized bone matrix scaffold enhances the recruitment and osteogenesis of mesenchymal stem cells by promoting inflammation resolution

Yao, D., & Lv, Y. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213036 · Cited by 18

The use of circulating miRNAs for the diagnosis, prognosis, and personalized treatment of MASLD

Tobaruela-Resola, A. L., Milagro, F. I., Mogna-Peláez, P., Moreno-Aliaga, M. J., Abete, I., & Zulet, M. Á. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01110-w · Cited by 17

Chemotactic cytokines secreted from Kupffer cells contribute to the sex-dependent susceptibility to non-alcoholic fatty liver diseases in mice

Han, Y., Choi, H., Kim, H., & Lee, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120846 · Cited by 17

Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90α axis

Liu, M., He, H., Fan, F., Qiu, L.-J., Zheng, F., Guan, Y., Yang, G., & Chen, L. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.05.005 · Cited by 17

Oxylipins Derived from PUFAs in Cardiometabolic Diseases: Mechanism of Actions and Possible Nutritional Interactions

Ağagündüz, D., Yeşildemir, Ö., Koçyiğit, E., Koçak, T., Ünaldı, B. Ö., Ayakdaş, G., & Budán, F. (2024) · Nutrients · doi:10.3390/nu16223812 · Cited by 18

Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication

Li, C., Wang, Z., Yang, Y., Jiang, Q., Jiang, Y., Xiao, J., Shen, L., Wu, W., & Li, C. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00400-5 · Cited by 22

Lipoxygenases in chronic liver diseases: current insights and future perspectives

Heinrich, L., Booijink, R. S., Khurana, A., Weiskirchen, R., & Bansal, R. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.12.001 · Cited by 16

IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis

Yao, L., Hu, X., Yuan, M., Zhang, Q., Liu, P., Yang, L., Dai, K., & Jiang, Y. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00392 · Cited by 15

The Role of Endogenous Specialized Proresolving Mediators in Mast Cells and Their Involvement in Inflammation and Resolution

Fukuishi, N., Takahama, K., Kurosaki, H., Ono, S., & Asai, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041491 · Cited by 18

Decreased Serum Maresin 1 Concentration Is Associated With Postmenopausal Osteoporosis: A Cross-Sectional Study

Wu, J. T., Li, X., Xia, F., Teng, F., & Xu, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.759825 · Cited by 15

Maternal diabetes-mediated RORA suppression contributes to gastrointestinal symptoms in autism-like mouse offspring

Xiao, L., Wang, M., Zhang, W., Song, Y., Zeng, J., Li, H., Yu, H. Y., Li, L., Gao, P., & Yao, P. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00693-0 · Cited by 16

Maresins as novel anti-inflammatory actors and putative therapeutic targets in sepsis

Sun, Y., Sun, S., Chen, P., Dai, Y., Yang, D. J., Lin, Y., & Yi, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107113 · Cited by 15

Specialized Pro-Resolving Mediators Derived from N-3 Polyunsaturated Fatty Acids: Role in Metabolic Syndrome and Related Complications

Dubé, L., Spahis, S., Lachaîne, K., Lemieux, A., Monhem, H., Poulin, S.-M., Randoll, C., Travaillaud, E., Ould-Chikh, N.-E.-H., Marcil, V., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0156 · Cited by 15

Exploiting oxidized lipids and the lipid‐binding GPCRs against cardiometabolic diseases

Guimarães, R. C., Gonçalves, T. T., & Leiria, L. O. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15321 · Cited by 15

Bioactive lipids and metabolic syndrome—a symposium report

DeVito, L. M., Dennis, E. A., Kahn, B. B., Shulman, G. I., Witztum, J. L., Sadhu, S., Nickels, J. T., Spite, M. R., Smyth, S. S., & Spiegel, S. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14752 · Cited by 12

Enzymatically-epoxidized docosahexaenoic acid, 19,20-EpDPE, suppresses hepatic crown-like structure formation and nonalcoholic steatohepatitis fibrosis through GPR120

Aoki, H., Isobe, Y., Yoshida, M., Kang, J. X., Maekawa, M., & Arita, M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159275 · Cited by 14

The pro-resolving lipid mediator Maresin 1 ameliorates pain responses and neuroinflammation in the spared nerve injury-induced neuropathic pain: A study in male and female mice

Teixeira-Santos, L., Martins, S., Sousa, T., Albino‐Teixeira, A., & Pinho, D. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287392 · Cited by 14

Narrative Review: Glucocorticoids in Alcoholic Hepatitis—Benefits, Side Effects, and Mechanisms

Lü, H. (2022) · Journal of Xenobiotics · doi:10.3390/jox12040019 · Cited by 13

n-3 polyunsaturated fatty acids regulate chemerin in cultured adipocytes: role of GPR120 and derived lipid mediators

Sáinź, N., Fernández‐Galilea, M., Costa, A. G. V., Prieto-Hontoria, P. L., Barraco, G. M., & Moreno-Aliaga, M. J. (2020) · Food & Function · doi:10.1039/d0fo01445a · Cited by 13

Mouse models of nonalcoholic steatohepatitis and their application to new drug development

Phung, H. H., & Lee, C. H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01410-5 · Cited by 13

The Proresolving Lipid Mediator Maresin1 Alleviates Experimental Pancreatitis via Switching Macrophage Polarization

Lu, Y., Lu, G., Gao, L., Zhu, Q., Xue, J., Zhang, J., Ma, X., Ma, N., Yang, Q., Dong, J., et al. (2021) · Mediators of Inflammation · doi:10.1155/2021/6680456 · Cited by 14

Exosome‐derived miR ‐142‐5p from liver stem cells improves the progression of liver fibrosis by regulating macrophage polarization through CTSB

Hu, Z., Zhao, Y., Jiang, J., Li, W., Su, G., Li, L., & Ran, J. (2023) · Environmental Toxicology · doi:10.1002/tox.23813 · Cited by 13

Resolving inflammation in nonalcoholic steatohepatitis

Spite, M. R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127583 · Cited by 9

RORα Induces KLF4-Mediated M2 Polarization in the Liver Macrophages that Protect against Nonalcoholic Steatohepatitis

Han, Y., Kim, H., Na, H., Nam, M.-W., Kim, J.-Y., Kim, J.-S., Koo, S., & Lee, M.-O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.017 · Cited by 154

RORα Decreases Oxidative Stress Through the Induction of SOD2 and GPx1 Expression and Thereby Protects Against Nonalcoholic Steatohepatitis in Mice

Han, Y., Kim, H., Kim, E., Kim, K.-S., Hong, S., Park, H., & Lee, M. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5655 · Cited by 86

Nobiletin Alleviates Non-alcoholic Steatohepatitis in MCD-Induced Mice by Regulating Macrophage Polarization

Wang, S.-W., Lan, T., Sheng, H., Zheng, F., Lei, M.-K., Wang, L.-X., Chen, H.-F., Xu, C.-Y., & Zhang, F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.687744 · Cited by 28

Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88‐mediated NF‐κB and MAPK pathways and activating the Nrf2 pathway in mice

Li, J., Deng, X., Bai, T., Wang, S., Jiang, Q., & Xu, K. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106961 · Cited by 55